PMHS flashcards
PMHS · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- M-CHAT-R/F timing
- Autism screening tool administered at 18 and 24 months; a positive result triggers follow-up interview and, if still positive, diagnostic evaluation-not diagnosis.
- PHQ-A severe threshold
- PHQ-A total of 20–27 indicates severe depression; any positive response to item 9 (suicidal ideation) requires immediate safety assessment regardless of total score.
- ADHD DSM-5-TR symptom threshold
- For children under 17, at least six inattentive and/or six hyperactive-impulsive symptoms are required; for ages 17 and older, the threshold is five symptoms.
- ADHD cross-setting requirement
- Symptoms must be present in two or more settings (home, school, community) and cause clear impairment; use parent and teacher rating scales to document this.
- SCARED anxiety cutoff
- Screen for Child Anxiety Related Emotional Disorders; a total score of 25 or higher suggests clinically significant anxiety and warrants further evaluation.
- Separation anxiety disorder duration
- DSM-5-TR requires developmentally inappropriate, persistent distress lasting at least four weeks that impairs functioning, distinguishing it from normative toddler separation distress.
- MDD duration in children
- Major depressive disorder requires at least two weeks of depressed mood or irritability plus associated symptoms; irritability may substitute for depressed mood in children.
- Medical mimics of psychiatric symptoms
- Thyroid disease, anemia, sleep apnea, medication effects, and substance use can mimic anxiety, depression, or ADHD; evaluate before assigning a psychiatric diagnosis.
- Preschool ADHD first-line
- For children ages 4–5, behavioral parent training is first-line before medication; stimulants are considered only if behavioral interventions are insufficient.
- Stimulant monitoring parameters
- Obtain baseline height, weight, blood pressure, and heart rate; recheck at dose changes and every visit; monitor appetite, sleep, tics, and cardiovascular symptoms.
- Fluoxetine pediatric approval
- Fluoxetine is FDA-approved for major depressive disorder in adolescents and has evidence for pediatric OCD; start low (10 mg) and titrate slowly.
- Antidepressant black box warning
- Antidepressants increase suicidality risk in patients under 25; provide education, close early follow-up, and safety planning, but do not withhold indicated treatment.
- SSRI discontinuation syndrome
- Abrupt SSRI cessation causes dizziness, nausea, irritability, and flu-like symptoms; taper gradually, though fluoxetine's long half-life reduces this risk.
- Suicide risk assessment
- Ask directly about ideation, plan, intent, and access to means; use C-SSRS or ASQ; remove lethal means and document a safety plan with follow-up.
- PCIT indication
- Parent-Child Interaction Therapy is an evidence-based treatment for disruptive behavior in young children (roughly ages 2–7), emphasizing live coaching of parent-child interactions.
- CBT for pediatric anxiety
- Cognitive-behavioral therapy with exposure is first-line psychotherapy for pediatric anxiety disorders and OCD; combine with SSRIs for moderate-to-severe cases.
- 504 plan versus IEP
- A 504 plan provides accommodations for a disability; an IEP provides special education services when a child meets eligibility criteria under IDEA.
- 988 Suicide and Crisis Lifeline
- The 988 dialing code connects callers to the Suicide and Crisis Lifeline; use for acute risk, and involve emergency services when risk is imminent.
- ADHD comorbidity patterns
- ADHD commonly co-occurs with oppositional defiant disorder, anxiety, learning disorders, and tic disorders; screen broadly rather than anchoring on a single diagnosis.
- Autism comorbidity screening
- Screen for intellectual disability, epilepsy, anxiety, ADHD, sleep disorders, and GI problems; avoid diagnosing ADHD without impairment beyond autism symptoms.
- TF-CBT indication
- Trauma-focused cognitive-behavioral therapy is first-line psychotherapy for children with PTSD or significant trauma symptoms; it includes caregiver involvement.
- Pediatric PTSD presentation
- Children with PTSD may show regression, aggression, hypervigilance, avoidance, or somatic complaints rather than classic adult re-experiencing symptoms.
- CRAFFT screening
- A brief adolescent substance use screen; a score of 2 or higher indicates need for further assessment and brief intervention or referral.
- Eating disorder medical instability
- Bradycardia, hypotension, hypothermia, orthostasis, or electrolyte abnormalities in an eating disorder warrant urgent medical evaluation or hospitalization.
- ARFID definition
- Avoidant/restrictive food intake disorder involves restrictive eating without body image disturbance, causing nutritional deficiency, weight loss, or psychosocial impairment.
- Sleep apnea before ADHD
- Rule out obstructive sleep apnea (snoring, daytime sleepiness) before attributing inattention or sleep problems to ADHD or anxiety.
- Developmental regression red flag
- Loss of previously acquired skills at any age warrants urgent evaluation for autism, seizure disorder, or neurodegenerative conditions rather than behavioral attribution.
- Transition planning age
- Adolescents with mental health conditions need a transition plan to adult care by age 18, coordinating school, family, and adult providers.
- ACE screening
- Adverse childhood experiences screening identifies trauma exposure; positive screens prompt trauma-informed care and consideration of TF-CBT or other evidence-based therapy.
- ASQ-3 domains
- Ages & Stages Questionnaires assess communication, gross motor, fine motor, problem-solving, and personal-social development; results guide referral for further evaluation.
- Vanderbilt rating scale use
- Parent and teacher Vanderbilt forms document ADHD symptom counts and impairment across settings, supporting DSM-5-TR cross-setting criteria and treatment monitoring.
- Selective mutism first-line
- Behavioral intervention with exposure-based strategies is first-line for selective mutism; SSRIs may be considered when impairment is significant or therapy is insufficient.